IL19 and neutropenia: mTORC1 activation enhances the production of IL-19 by osteocytes, and IL-19 has been proven to be a robust stimulation of granulopoieses, relieving chemotherapy- and irradiation-induced neutropenia even more effectively than G-CSF (126).